{"publish_date":{"8028175":20141206,"8021994":20141206},"url":{"8028175":"http:\/\/www.countytimes.com\/articles\/2014\/12\/05\/news\/doc548285dc53dbe674482228.txt","8021994":"http:\/\/finance.yahoo.com\/news\/seattle-genetics-takeda-report-phase-160000527.html"},"topic":{"8028175":"moldf","8021994":"moldf"},"model1_prediction":{"8028175":1,"8021994":1},"model1_prediction_prob":{"8028175":0.6283148483,"8021994":0.5653501415},"title":{"8028175":"Data: Half of State\u2019s Hospitals Exceed Infection Rates","8021994":"Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS\u00ae (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting"}}